Marion Odence-Ford
Known title: General Counsel and CCOCIK: 0001845002
Marion Odence-Ford's purchase track record
Marion Odence-Ford has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/26/2022 | OPRX | $16K | +26.2% | +9.0% | -2.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OPRX | ▼ Sell | Tax Withholding | 1,529 | $12K | 8/21/2026 | View on chart |
| OPRX | ▲ Buy | Grant | 57,600 | $0 | 8/20/2026 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 4,000 | — | 2/11/2026 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,386 | $13K | 2/11/2026 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 4,051 | $52K | 12/23/2025 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 3,928 | $0 | 12/19/2025 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,153 | $16K | 12/19/2025 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,952 | $37K | 10/3/2025 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 6,649 | $0 | 10/3/2025 | View on chart |
| OPRX | ▲ Buy | Grant | 15,625 | $0 | 8/21/2025 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 771 | $0 | 3/1/2025 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 268 | $1K | 3/1/2025 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,479 | $10K | 2/15/2025 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 4,000 | — | 2/11/2025 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,386 | $8K | 2/11/2025 | View on chart |
| OPRX | ▲ Buy | Grant | 41,408 | $0 | 12/23/2024 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,153 | $5K | 12/20/2024 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 3,927 | $0 | 12/19/2024 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 1,785 | $0 | 11/8/2024 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 524 | $3K | 11/8/2024 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,952 | $15K | 10/3/2024 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 6,649 | $0 | 10/3/2024 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 268 | $4K | 3/1/2024 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 771 | $0 | 3/1/2024 | View on chart |
| OPRX | ▲ Buy | Grant | 4,267 | $0 | 2/15/2024 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,386 | $21K | 2/11/2024 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 4,000 | $0 | 2/11/2024 | View on chart |
| OPRX | ▼ Sell | Open Market | 4,000 | $61K | 1/9/2024 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 1,785 | $0 | 11/8/2023 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 524 | $5K | 11/8/2023 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,952 | $14K | 10/3/2023 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 6,649 | $0 | 10/3/2023 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 771 | $0 | 3/1/2023 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 268 | $5K | 3/1/2023 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 1,422 | $25K | 2/11/2023 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 4,000 | $0 | 2/11/2023 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 1,785 | $0 | 11/8/2022 | View on chart |
| OPRX | ▼ Sell | Tax Withholding | 710 | $10K | 11/8/2022 | View on chart |
| OPRX | ▲ Buy | Open Market | 1,000 | $16K | 8/26/2022 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 4,000 | — | 2/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
OptimizeRx Expands Ad Reach via OpenPath Deal with The Trade Desk
OptimizeRx has announced a partnership with The Trade Desk that uses its OpenPath platform to add authenticated healthcare professional reach to the ad network. The deal is expected to broaden the company’s inventory and provide advertisers with more precise targeting in the healthcare space. This collaboration follows a series of moves to grow OptimizeRx’s presence in the digital advertising market.
OptimizeRx Expands Ad Reach via OpenPath Deal with The Trade Desk. OptimizeRx has announced a partnership with The Trade Desk that uses its OpenPath platform to add authenticated healthcare professional reach to the ad network. The deal is expected to broaden the company’s inventory and provide advertisers with more precise targeting in the healthcare space. This collaboration follows a series of moves to grow OptimizeRx’s presence in the digital advertising market.